三个皮匠报告
最新
报告分类 研搜
BETA
政策库
自研报告
new
入驻
搜索
您的当前位置：首页 > 行业数据 > 泰它西普与贝利尤单抗SLE患者中IgM、IgG及IgA较基线降低百分比中位数比较
图片属性
图片格式：PNG 图片大小：201KB 图片尺寸：1798*921
同报告图片
 / 4
泰它西普与贝利尤单抗SLE患者中IgM、IgG及IgA较基线降低百分比中位数比较_第1页
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
泰它西普与贝利尤单抗SLE患者中IgM、IgG及IgA较基线降低百分比中位数比较_第2页
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
泰它西普与贝利尤单抗SLE患者中IgM、IgG及IgA较基线降低百分比中位数比较_第3页
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
泰它西普与贝利尤单抗SLE患者中IgM、IgG及IgA较基线降低百分比中位数比较_第4页
泰它西普与贝利尤单抗SLE患者中IgM、IgG及IgA较基线降低百分比中位数比较_第5页
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
所属报告： 荣昌生物-公司深度报告：ADC+自免双驱期待国际化突破-240326（30页）.pdf
打包全文图表

相关数据

最新数据
全行业研究报告分享下载平台
  • 0731-84720580
  • 商务合作：really158d
关于我们
更多
关于我们
三个皮匠报告微信公众号
三个皮匠报告微信小程序
扫码咨询网站充值下载问题
copyright@2008-2013 长沙景略智创信息技术有限公司版权所有        网站备案/许可证号：湘B2-20190120 | 工信部备案号：湘ICP备17000430号-2 | 公安备案号：湘公网安备43010402001071号
客服
商务合作
小程序
服务号
折叠